Cell therapy startup Eyestem raises ₹51 crore from BE, Alkem & Natco

Eyestem, a Bengaluru-based cell therapy company, on Monday, said it has raised Rs 51 crore in a Series A round led by three pharma majors — Biological E (BE), Alkem, Natco NSE -4.77 % and Anurag and Karan Bagaria, promoters of Kemwell Biopharma.

Existing investors Endiya Partners and Kotak Private Equity also participated in this round, valuing Eyestem at $46.4 million (INR 371 Crore) post-money.